ORTHO CLINICAL DIAGNOSTIC "VITROS" NEPHROCHECK TEST FOR PREDICTION OF ACUTE KIDNEY INJURY CLEARED AVAILABLE IN EUROPE

PR Newswire - Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced the launch of its VITROS NephroCheck test, the first fully automated risk assessment tool for predicting Acute Kidney Injury (AKI), a serious and potentially fatal condition affecting hospital patients worldwide. The test has received CE Mark clearance, signifying conformance to all EU regulations, and is now available for purchase and use on Ortho's VITROS Systems in Europe. AKI, the sudden loss of kidney function, can develop without warning and potentially lead to kidney failure and death. Known as a silent killer, AKI is as common and twice as deadly as a heart attack causing as many as two million deaths annually worldwide AKI is caused by renal stress contributed to by major surgery, drugs, toxins, serious infection, or chronic illness and trauma. Up to 50 percent of patients... >>>